These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20736943)

  • 1. Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients.
    Mailliez A; Baldini C; Van JT; Servent V; Mallet Y; Bonneterre J
    Br J Cancer; 2010 Sep; 103(6):772-5. PubMed ID: 20736943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nasal septum perforation and bevacizumab].
    Bengrine-Lefevre L; Afchain P; Chibaudel B; Gervais H; Tournigand C; De Gramont A; Louvet C
    Rev Med Interne; 2011 Apr; 32(4):e43-5. PubMed ID: 21470582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer.
    Traina TA; Norton L; Drucker K; Singh B
    Oncologist; 2006; 11(10):1070-1. PubMed ID: 17110625
    [No Abstract]   [Full Text] [Related]  

  • 4. A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer.
    Petrelli F; Cabiddu M; Barbara C; Barni S
    Breast Cancer; 2011 Jul; 18(3):226-30. PubMed ID: 21312011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal septum perforation and bevacizumab.
    Power DG; Kemeny NE
    Med Oncol; 2011 Mar; 28(1):89-93. PubMed ID: 20213219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal septum perforation in a breast cancer patient treated with bevacizumab.
    Marín AP; Sánchez AR; Arranz EE
    Ann Oncol; 2009 Nov; 20(11):1901-2. PubMed ID: 19752003
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy.
    Burkart CM; Grisel JJ; Hom DB
    Laryngoscope; 2008 Sep; 118(9):1539-41. PubMed ID: 18622319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
    Rodriguez CA; Martin T; Lozano R; Gomez A; Cruz JJ
    Breast J; 2017 Nov; 23(6):745-746. PubMed ID: 28845572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer.
    Croom KF; Dhillon S
    Drugs; 2011 Nov; 71(16):2213-29. PubMed ID: 22035518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers.
    Baar J; Silverman P; Lyons J; Fu P; Abdul-Karim F; Ziats N; Wasman J; Hartman P; Jesberger J; Dumadag L; Hohler E; Leeming R; Shenk R; Chen H; McCrae K; Dowlati A; Remick SC; Overmoyer B
    Clin Cancer Res; 2009 May; 15(10):3583-90. PubMed ID: 19417018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab-induced nasal septum perforation.
    Fakih MG; Lombardo JC
    Oncologist; 2006 Jan; 11(1):85-6. PubMed ID: 16401718
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
    Chen S; Karnezis T; Davidson TM
    Laryngoscope; 2011 Mar; 121(3):644-6. PubMed ID: 21344447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study.
    Boulaamane L; Boutayeb S; Errihani H
    BMC Res Notes; 2012 Mar; 5():162. PubMed ID: 22439740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer.
    Rodgers M; Soares M; Epstein D; Yang H; Fox D; Eastwood A
    Health Technol Assess; 2011 May; 15 Suppl 1():1-12. PubMed ID: 21609648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
    Burstein HJ; Chen YH; Parker LM; Savoie J; Younger J; Kuter I; Ryan PD; Garber JE; Chen H; Campos SM; Shulman LN; Harris LN; Gelman R; Winer EP
    Clin Cancer Res; 2008 Dec; 14(23):7871-7. PubMed ID: 19047116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer.
    Perez EA; Hillman DW; Dentchev T; Le-Lindqwister NA; Geeraerts LH; Fitch TR; Liu H; Graham DL; Kahanic SP; Gross HM; Patel TA; Palmieri FM; Dueck AC
    Ann Oncol; 2010 Feb; 21(2):269-274. PubMed ID: 19901014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab in the treatment of breast cancer.
    Sirohi B; Smith K
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1559-68. PubMed ID: 18925848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of docetaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (TORI B01).
    Hurvitz SA; Allen HJ; Moroose RL; Chan D; Hagenstad C; Applebaum SH; Patel G; Hu EH; Ryba N; Lin LS; Wang H; Glaspy J; Slamon DJ; Kabbinavar F
    Clin Breast Cancer; 2010 Aug; 10(4):307-12. PubMed ID: 20705564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five arm natural history study of nasal vestibulitis.
    Cathcart-Rake EJ; Zahrieh D; Smith D; Young S; McCue S; O'Connor A; Thomé S; Lacouture M; Register T; Piens J; Friday BB; Loprinzi CL
    Cancer Med; 2023 Apr; 12(8):9650-9654. PubMed ID: 37017603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer.
    Schwartzberg LS; Badarinath S; Keaton MR; Childs BH
    Clin Breast Cancer; 2014 Jun; 14(3):161-8. PubMed ID: 24566467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.